Irinotecan liposome Intravenous and Mogamulizumab-kpkc Intravenous
Determining the interaction of Irinotecan liposome Intravenous and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: irinotecan liposomal
Brand name: Onivyde
Synonyms: Irinotecan liposomal, Irinotecan (Liposomal)
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Irinotecan liposome Intravenous-Molindone
- Irinotecan liposome Intravenous-Mometasone (Oral Inhalation)
- Irinotecan liposome Intravenous-Mometasone and Formoterol
- Irinotecan liposome Intravenous-Mometasone and formoterol Inhalation
- Irinotecan liposome Intravenous-Mometasone Cream
- Irinotecan liposome Intravenous-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Iron 100/C
- Mogamulizumab-kpkc Intravenous-Iron 21/7
- Mogamulizumab-kpkc Intravenous-Iron and Docusate
- Mogamulizumab-kpkc Intravenous-Iron and Folic Acid
- Mogamulizumab-kpkc Intravenous-Iron and Vitamin C
- Mogamulizumab-kpkc Intravenous-Iron Chewable Tablets